N-[2-[[1-[4-(5-bromo-2-pyridinyl)-4-hydroxycyclohexyl]azetidin-3-yl]amino]-2-oxoethyl]-3-methylbenzamide;N-[2-[[1-[4-[6-(dimethylamino)-3-pyridinyl]-4-hydroxycyclohexyl]azetidin-3-yl]amino]-2-oxoethyl]-3-methylbenzamide;N-[2-[[1-[4-hydroxy-4-(6-methoxy-3-pyridinyl)cyclohexyl]azetidin-3-yl]amino]-2-oxoethyl]-3-methoxybenzamide;N-[2-[[1-[4-hydroxy-4-(6-methoxy-3-pyridinyl)cyclohexyl]azetidin-3-yl]amino]-2-oxoethyl]-3-methylbenzamide;N-[2-[[1-(4-hydroxy-4-pyrimidin-5-ylcyclohexyl)azetidin-3-yl]amino]-2-oxoethyl]-3-(trifluoromethyl)benzamide

C123H154BrF3N22O18 — CID 160787193

IUPACN-[2-[[1-[4-(5-bromo-2-pyridinyl)-4-hydroxycyclohexyl]azetidin-3-yl]amino]-2-oxoethyl]-3-methylbenzamide;N-[2-[[1-[4-[6-(dimethylamino)-3-pyridinyl]-4-hydroxycyclohexyl]azetidin-3-yl]amino]-2-oxoethyl]-3-methylbenzamide;N-[2-[[1-[4-hydroxy-4-(6-methoxy-3-pyridinyl)cyclohexyl]azetidin-3-yl]amino]-2-oxoethyl]-3-methoxybenzamide;N-[2-[[1-[4-hydroxy-4-(6-methoxy-3-pyridinyl)cyclohexyl]azetidin-3-yl]amino]-2-oxoethyl]-3-methylbenzamide;N-[2-[[1-(4-hydroxy-4-pyrimidin-5-ylcyclohexyl)azetidin-3-yl]amino]-2-oxoethyl]-3-(trifluoromethyl)benzamide
SMILESCOc1ccc(C2(O)CCC(N3CC(NC(=O)CNC(=O)c4cccc(C)c4)C3)CC2)cn1.COc1cccc(C(=O)NCC(=O)NC2CN(C3CCC(O)(c4ccc(OC)nc4)CC3)C2)c1.Cc1cccc(C(=O)NCC(=O)NC2CN(C3CCC(O)(c4ccc(Br)cn4)CC3)C2)c1.Cc1cccc(C(=O)NCC(=O)NC2CN(C3CCC(O)(c4ccc(N(C)C)nc4)CC3)C2)c1.O=C(CNC(=O)c1cccc(C(F)(F)F)c1)NC1CN(C2CCC(O)(c3cncnc3)CC2)C1
InChIInChI=1S/C26H35N5O3.C25H32N4O5.C25H32N4O4.C24H29BrN4O3.C23H26F3N5O3/c1-18-5-4-6-19(13-18)25(33)28-15-24(32)29-21-16-31(17-21)22-9-11-26(34,12-10-22)20-7-8-23(27-14-20)30(2)3;1-33-21-5-3-4-17(12-21)24(31)27-14-22(30)28-19-15-29(16-19)20-8-10-25(32,11-9-20)18-6-7-23(34-2)26-13-18;1-17-4-3-5-18(12-17)24(31)27-14-22(30)28-20-15-29(16-20)21-8-10-25(32,11-9-21)19-6-7-23(33-2)26-13-19;1-16-3-2-4-17(11-16)23(31)27-13-22(30)28-19-14-29(15-19)20-7-9-24(32,10-8-20)21-6-5-18(25)12-26-21;24-23(25,26)16-3-1-2-15(8-16)21(33)29-11-20(32)30-18-12-31(13-18)19-4-6-22(34,7-5-19)17-9-27-14-28-10-17/h4-8,13-14,21-22,34H,9-12,15-17H2,1-3H3,(H,28,33)(H,29,32);3-7,12-13,19-20,32H,8-11,14-16H2,1-2H3,(H,27,31)(H,28,30);3-7,12-13,20-21,32H,8-11,14-16H2,1-2H3,(H,27,31)(H,28,30);2-6,11-12,19-20,32H,7-10,13-15H2,1H3,(H,27,31)(H,28,30);1-3,8-10,14,18-19,34H,4-7,11-13H2,(H,29,33)(H,30,32)
InChIKeySBJATPDUXHHVIF-UHFFFAOYSA-N
MW2365.62 g/mol
LogP9.40
Rot. Bonds34

About N-[2-[[1-[4-(5-bromo-2-pyridinyl)-4-hydroxycyclohexyl]azetidin-3-yl]amino]-2-oxoethyl]-3-methylbenzamide;N-[2-[[1-[4-[6-(dimethylamino)-3-pyridinyl]-4-hydroxycyclohexyl]azetidin-3-yl]amino]-2-oxoethyl]-3-methylbenzamide;N-[2-[[1-[4-hydroxy-4-(6-methoxy-3-pyridinyl)cyclohexyl]azetidin-3-yl]amino]-2-oxoethyl]-3-methoxybenzamide;N-[2-[[1-[4-hydroxy-4-(6-methoxy-3-pyridinyl)cyclohexyl]azetidin-3-yl]amino]-2-oxoethyl]-3-methylbenzamide;N-[2-[[1-(4-hydroxy-4-pyrimidin-5-ylcyclohexyl)azetidin-3-yl]amino]-2-oxoethyl]-3-(trifluoromethyl)benzamide

N-[2-[[1-[4-(5-bromo-2-pyridinyl)-4-hydroxycyclohexyl]azetidin-3-yl]amino]-2-oxoethyl]-3-methylbenzamide;N-[2-[[1-[4-[6-(dimethylamino)-3-pyridinyl]-4-hydroxycyclohexyl]azetidin-3-yl]amino]-2-oxoethyl]-3-methylbenzamide;N-[2-[[1-[4-hydroxy-4-(6-methoxy-3-pyridinyl)cyclohexyl]azetidin-3-yl]amino]-2-oxoethyl]-3-methoxybenzamide;N-[2-[[1-[4-hydroxy-4-(6-methoxy-3-pyridinyl)cyclohexyl]azetidin-3-yl]amino]-2-oxoethyl]-3-methylbenzamide;N-[2-[[1-(4-hydroxy-4-pyrimidin-5-ylcyclohexyl)azetidin-3-yl]amino]-2-oxoethyl]-3-(trifluoromethyl)benzamide (PubChem CID 160787193) has the molecular formula C123H154BrF3N22O18 and a molecular weight of 2365.62 g/mol. Its IUPAC name is N-[2-[[1-[4-(5-bromo-2-pyridinyl)-4-hydroxycyclohexyl]azetidin-3-yl]amino]-2-oxoethyl]-3-methylbenzamide;N-[2-[[1-[4-[6-(dimethylamino)-3-pyridinyl]-4-hydroxycyclohexyl]azetidin-3-yl]amino]-2-oxoethyl]-3-methylbenzamide;N-[2-[[1-[4-hydroxy-4-(6-methoxy-3-pyridinyl)cyclohexyl]azetidin-3-yl]amino]-2-oxoethyl]-3-methoxybenzamide;N-[2-[[1-[4-hydroxy-4-(6-methoxy-3-pyridinyl)cyclohexyl]azetidin-3-yl]amino]-2-oxoethyl]-3-methylbenzamide;N-[2-[[1-(4-hydroxy-4-pyrimidin-5-ylcyclohexyl)azetidin-3-yl]amino]-2-oxoethyl]-3-(trifluoromethyl)benzamide.

Molecular Properties

Compound NameN-[2-[[1-[4-(5-bromo-2-pyridinyl)-4-hydroxycyclohexyl]azetidin-3-yl]amino]-2-oxoethyl]-3-methylbenzamide;N-[2-[[1-[4-[6-(dimethylamino)-3-pyridinyl]-4-hydroxycyclohexyl]azetidin-3-yl]amino]-2-oxoethyl]-3-methylbenzamide;N-[2-[[1-[4-hydroxy-4-(6-methoxy-3-pyridinyl)cyclohexyl]azetidin-3-yl]amino]-2-oxoethyl]-3-methoxybenzamide;N-[2-[[1-[4-hydroxy-4-(6-methoxy-3-pyridinyl)cyclohexyl]azetidin-3-yl]amino]-2-oxoethyl]-3-methylbenzamide;N-[2-[[1-(4-hydroxy-4-pyrimidin-5-ylcyclohexyl)azetidin-3-yl]amino]-2-oxoethyl]-3-(trifluoromethyl)benzamide
PubChem CID160787193
Molecular FormulaC123H154BrF3N22O18
Molecular Weight2365.62 g/mol
Exact Mass2363.09
IUPAC NameN-[2-[[1-[4-(5-bromo-2-pyridinyl)-4-hydroxycyclohexyl]azetidin-3-yl]amino]-2-oxoethyl]-3-methylbenzamide;N-[2-[[1-[4-[6-(dimethylamino)-3-pyridinyl]-4-hydroxycyclohexyl]azetidin-3-yl]amino]-2-oxoethyl]-3-methylbenzamide;N-[2-[[1-[4-hydroxy-4-(6-methoxy-3-pyridinyl)cyclohexyl]azetidin-3-yl]amino]-2-oxoethyl]-3-methoxybenzamide;N-[2-[[1-[4-hydroxy-4-(6-methoxy-3-pyridinyl)cyclohexyl]azetidin-3-yl]amino]-2-oxoethyl]-3-methylbenzamide;N-[2-[[1-(4-hydroxy-4-pyrimidin-5-ylcyclohexyl)azetidin-3-yl]amino]-2-oxoethyl]-3-(trifluoromethyl)benzamide
SMILESCOc1ccc(C2(O)CCC(N3CC(NC(=O)CNC(=O)c4cccc(C)c4)C3)CC2)cn1.COc1cccc(C(=O)NCC(=O)NC2CN(C3CCC(O)(c4ccc(OC)nc4)CC3)C2)c1.Cc1cccc(C(=O)NCC(=O)NC2CN(C3CCC(O)(c4ccc(Br)cn4)CC3)C2)c1.Cc1cccc(C(=O)NCC(=O)NC2CN(C3CCC(O)(c4ccc(N(C)C)nc4)CC3)C2)c1.O=C(CNC(=O)c1cccc(C(F)(F)F)c1)NC1CN(C2CCC(O)(c3cncnc3)CC2)C1
InChIInChI=1S/C26H35N5O3.C25H32N4O5.C25H32N4O4.C24H29BrN4O3.C23H26F3N5O3/c1-18-5-4-6-19(13-18)25(33)28-15-24(32)29-21-16-31(17-21)22-9-11-26(34,12-10-22)20-7-8-23(27-14-20)30(2)3;1-33-21-5-3-4-17(12-21)24(31)27-14-22(30)28-19-15-29(16-19)20-8-10-25(32,11-9-20)18-6-7-23(34-2)26-13-18;1-17-4-3-5-18(12-17)24(31)27-14-22(30)28-20-15-29(16-20)21-8-10-25(32,11-9-21)19-6-7-23(33-2)26-13-19;1-16-3-2-4-17(11-16)23(31)27-13-22(30)28-19-14-29(15-19)20-7-9-24(32,10-8-20)21-6-5-18(25)12-26-21;24-23(25,26)16-3-1-2-15(8-16)21(33)29-11-20(32)30-18-12-31(13-18)19-4-6-22(34,7-5-19)17-9-27-14-28-10-17/h4-8,13-14,21-22,34H,9-12,15-17H2,1-3H3,(H,28,33)(H,29,32);3-7,12-13,19-20,32H,8-11,14-16H2,1-2H3,(H,27,31)(H,28,30);3-7,12-13,20-21,32H,8-11,14-16H2,1-2H3,(H,27,31)(H,28,30);2-6,11-12,19-20,32H,7-10,13-15H2,1H3,(H,27,31)(H,28,30);1-3,8-10,14,18-19,34H,4-7,11-13H2,(H,29,33)(H,30,32)
InChIKeySBJATPDUXHHVIF-UHFFFAOYSA-N
XLogP9.40
TPSA516.62 Ų
H-Bond Donors15
H-Bond Acceptors30
Rotatable Bonds34
Heavy Atoms167
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5002365.62
LogP ≤ 59.40
H-Bond Donors ≤ 515
H-Bond Acceptors ≤ 1030

Analyze N-[2-[[1-[4-(5-bromo-2-pyridinyl)-4-hydroxycyclohexyl]azetidin-3-yl]amino]-2-oxoethyl]-3-methylbenzamide;N-[2-[[1-[4-[6-(dimethylamino)-3-pyridinyl]-4-hydroxycyclohexyl]azetidin-3-yl]amino]-2-oxoethyl]-3-methylbenzamide;N-[2-[[1-[4-hydroxy-4-(6-methoxy-3-pyridinyl)cyclohexyl]azetidin-3-yl]amino]-2-oxoethyl]-3-methoxybenzamide;N-[2-[[1-[4-hydroxy-4-(6-methoxy-3-pyridinyl)cyclohexyl]azetidin-3-yl]amino]-2-oxoethyl]-3-methylbenzamide;N-[2-[[1-(4-hydroxy-4-pyrimidin-5-ylcyclohexyl)azetidin-3-yl]amino]-2-oxoethyl]-3-(trifluoromethyl)benzamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of N-[2-[[1-[4-(5-bromo-2-pyridinyl)-4-hydroxycyclohexyl]azetidin-3-yl]amino]-2-oxoethyl]-3-methylbenzamide;N-[2-[[1-[4-[6-(dimethylamino)-3-pyridinyl]-4-hydroxycyclohexyl]azetidin-3-yl]amino]-2-oxoethyl]-3-methylbenzamide;N-[2-[[1-[4-hydroxy-4-(6-methoxy-3-pyridinyl)cyclohexyl]azetidin-3-yl]amino]-2-oxoethyl]-3-methoxybenzamide;N-[2-[[1-[4-hydroxy-4-(6-methoxy-3-pyridinyl)cyclohexyl]azetidin-3-yl]amino]-2-oxoethyl]-3-methylbenzamide;N-[2-[[1-(4-hydroxy-4-pyrimidin-5-ylcyclohexyl)azetidin-3-yl]amino]-2-oxoethyl]-3-(trifluoromethyl)benzamide?
The IUPAC name of N-[2-[[1-[4-(5-bromo-2-pyridinyl)-4-hydroxycyclohexyl]azetidin-3-yl]amino]-2-oxoethyl]-3-methylbenzamide;N-[2-[[1-[4-[6-(dimethylamino)-3-pyridinyl]-4-hydroxycyclohexyl]azetidin-3-yl]amino]-2-oxoethyl]-3-methylbenzamide;N-[2-[[1-[4-hydroxy-4-(6-methoxy-3-pyridinyl)cyclohexyl]azetidin-3-yl]amino]-2-oxoethyl]-3-methoxybenzamide;N-[2-[[1-[4-hydroxy-4-(6-methoxy-3-pyridinyl)cyclohexyl]azetidin-3-yl]amino]-2-oxoethyl]-3-methylbenzamide;N-[2-[[1-(4-hydroxy-4-pyrimidin-5-ylcyclohexyl)azetidin-3-yl]amino]-2-oxoethyl]-3-(trifluoromethyl)benzamide (CID 160787193) is N-[2-[[1-[4-(5-bromo-2-pyridinyl)-4-hydroxycyclohexyl]azetidin-3-yl]amino]-2-oxoethyl]-3-methylbenzamide;N-[2-[[1-[4-[6-(dimethylamino)-3-pyridinyl]-4-hydroxycyclohexyl]azetidin-3-yl]amino]-2-oxoethyl]-3-methylbenzamide;N-[2-[[1-[4-hydroxy-4-(6-methoxy-3-pyridinyl)cyclohexyl]azetidin-3-yl]amino]-2-oxoethyl]-3-methoxybenzamide;N-[2-[[1-[4-hydroxy-4-(6-methoxy-3-pyridinyl)cyclohexyl]azetidin-3-yl]amino]-2-oxoethyl]-3-methylbenzamide;N-[2-[[1-(4-hydroxy-4-pyrimidin-5-ylcyclohexyl)azetidin-3-yl]amino]-2-oxoethyl]-3-(trifluoromethyl)benzamide.
What is the SMILES notation for N-[2-[[1-[4-(5-bromo-2-pyridinyl)-4-hydroxycyclohexyl]azetidin-3-yl]amino]-2-oxoethyl]-3-methylbenzamide;N-[2-[[1-[4-[6-(dimethylamino)-3-pyridinyl]-4-hydroxycyclohexyl]azetidin-3-yl]amino]-2-oxoethyl]-3-methylbenzamide;N-[2-[[1-[4-hydroxy-4-(6-methoxy-3-pyridinyl)cyclohexyl]azetidin-3-yl]amino]-2-oxoethyl]-3-methoxybenzamide;N-[2-[[1-[4-hydroxy-4-(6-methoxy-3-pyridinyl)cyclohexyl]azetidin-3-yl]amino]-2-oxoethyl]-3-methylbenzamide;N-[2-[[1-(4-hydroxy-4-pyrimidin-5-ylcyclohexyl)azetidin-3-yl]amino]-2-oxoethyl]-3-(trifluoromethyl)benzamide?
The canonical SMILES for N-[2-[[1-[4-(5-bromo-2-pyridinyl)-4-hydroxycyclohexyl]azetidin-3-yl]amino]-2-oxoethyl]-3-methylbenzamide;N-[2-[[1-[4-[6-(dimethylamino)-3-pyridinyl]-4-hydroxycyclohexyl]azetidin-3-yl]amino]-2-oxoethyl]-3-methylbenzamide;N-[2-[[1-[4-hydroxy-4-(6-methoxy-3-pyridinyl)cyclohexyl]azetidin-3-yl]amino]-2-oxoethyl]-3-methoxybenzamide;N-[2-[[1-[4-hydroxy-4-(6-methoxy-3-pyridinyl)cyclohexyl]azetidin-3-yl]amino]-2-oxoethyl]-3-methylbenzamide;N-[2-[[1-(4-hydroxy-4-pyrimidin-5-ylcyclohexyl)azetidin-3-yl]amino]-2-oxoethyl]-3-(trifluoromethyl)benzamide is COc1ccc(C2(O)CCC(N3CC(NC(=O)CNC(=O)c4cccc(C)c4)C3)CC2)cn1.COc1cccc(C(=O)NCC(=O)NC2CN(C3CCC(O)(c4ccc(OC)nc4)CC3)C2)c1.Cc1cccc(C(=O)NCC(=O)NC2CN(C3CCC(O)(c4ccc(Br)cn4)CC3)C2)c1.Cc1cccc(C(=O)NCC(=O)NC2CN(C3CCC(O)(c4ccc(N(C)C)nc4)CC3)C2)c1.O=C(CNC(=O)c1cccc(C(F)(F)F)c1)NC1CN(C2CCC(O)(c3cncnc3)CC2)C1.
What is the InChIKey of N-[2-[[1-[4-(5-bromo-2-pyridinyl)-4-hydroxycyclohexyl]azetidin-3-yl]amino]-2-oxoethyl]-3-methylbenzamide;N-[2-[[1-[4-[6-(dimethylamino)-3-pyridinyl]-4-hydroxycyclohexyl]azetidin-3-yl]amino]-2-oxoethyl]-3-methylbenzamide;N-[2-[[1-[4-hydroxy-4-(6-methoxy-3-pyridinyl)cyclohexyl]azetidin-3-yl]amino]-2-oxoethyl]-3-methoxybenzamide;N-[2-[[1-[4-hydroxy-4-(6-methoxy-3-pyridinyl)cyclohexyl]azetidin-3-yl]amino]-2-oxoethyl]-3-methylbenzamide;N-[2-[[1-(4-hydroxy-4-pyrimidin-5-ylcyclohexyl)azetidin-3-yl]amino]-2-oxoethyl]-3-(trifluoromethyl)benzamide?
The InChIKey is SBJATPDUXHHVIF-UHFFFAOYSA-N. The full InChI is InChI=1S/C26H35N5O3.C25H32N4O5.C25H32N4O4.C24H29BrN4O3.C23H26F3N5O3/c1-18-5-4-6-19(13-18)25(33)28-15-24(32)29-21-16-31(17-21)22-9-11-26(34,12-10-22)20-7-8-23(27-14-20)30(2)3;1-33-21-5-3-4-17(12-21)24(31)27-14-22(30)28-19-15-29(16-19)20-8-10-25(32,11-9-20)18-6-7-23(34-2)26-13-18;1-17-4-3-5-18(12-17)24(31)27-14-22(30)28-20-15-29(16-20)21-8-10-25(32,11-9-21)19-6-7-23(33-2)26-13-19;1-16-3-2-4-17(11-16)23(31)27-13-22(30)28-19-14-29(15-19)20-7-9-24(32,10-8-20)21-6-5-18(25)12-26-21;24-23(25,26)16-3-1-2-15(8-16)21(33)29-11-20(32)30-18-12-31(13-18)19-4-6-22(34,7-5-19)17-9-27-14-28-10-17/h4-8,13-14,21-22,34H,9-12,15-17H2,1-3H3,(H,28,33)(H,29,32);3-7,12-13,19-20,32H,8-11,14-16H2,1-2H3,(H,27,31)(H,28,30);3-7,12-13,20-21,32H,8-11,14-16H2,1-2H3,(H,27,31)(H,28,30);2-6,11-12,19-20,32H,7-10,13-15H2,1H3,(H,27,31)(H,28,30);1-3,8-10,14,18-19,34H,4-7,11-13H2,(H,29,33)(H,30,32).
What are the key properties of N-[2-[[1-[4-(5-bromo-2-pyridinyl)-4-hydroxycyclohexyl]azetidin-3-yl]amino]-2-oxoethyl]-3-methylbenzamide;N-[2-[[1-[4-[6-(dimethylamino)-3-pyridinyl]-4-hydroxycyclohexyl]azetidin-3-yl]amino]-2-oxoethyl]-3-methylbenzamide;N-[2-[[1-[4-hydroxy-4-(6-methoxy-3-pyridinyl)cyclohexyl]azetidin-3-yl]amino]-2-oxoethyl]-3-methoxybenzamide;N-[2-[[1-[4-hydroxy-4-(6-methoxy-3-pyridinyl)cyclohexyl]azetidin-3-yl]amino]-2-oxoethyl]-3-methylbenzamide;N-[2-[[1-(4-hydroxy-4-pyrimidin-5-ylcyclohexyl)azetidin-3-yl]amino]-2-oxoethyl]-3-(trifluoromethyl)benzamide?
N-[2-[[1-[4-(5-bromo-2-pyridinyl)-4-hydroxycyclohexyl]azetidin-3-yl]amino]-2-oxoethyl]-3-methylbenzamide;N-[2-[[1-[4-[6-(dimethylamino)-3-pyridinyl]-4-hydroxycyclohexyl]azetidin-3-yl]amino]-2-oxoethyl]-3-methylbenzamide;N-[2-[[1-[4-hydroxy-4-(6-methoxy-3-pyridinyl)cyclohexyl]azetidin-3-yl]amino]-2-oxoethyl]-3-methoxybenzamide;N-[2-[[1-[4-hydroxy-4-(6-methoxy-3-pyridinyl)cyclohexyl]azetidin-3-yl]amino]-2-oxoethyl]-3-methylbenzamide;N-[2-[[1-(4-hydroxy-4-pyrimidin-5-ylcyclohexyl)azetidin-3-yl]amino]-2-oxoethyl]-3-(trifluoromethyl)benzamide has a molecular weight of 2365.62 g/mol, XLogP of 9.40, 34 rotatable bonds, 15 hydrogen bond donors, and 30 hydrogen bond acceptors.
Where does this data come from?
All data for N-[2-[[1-[4-(5-bromo-2-pyridinyl)-4-hydroxycyclohexyl]azetidin-3-yl]amino]-2-oxoethyl]-3-methylbenzamide;N-[2-[[1-[4-[6-(dimethylamino)-3-pyridinyl]-4-hydroxycyclohexyl]azetidin-3-yl]amino]-2-oxoethyl]-3-methylbenzamide;N-[2-[[1-[4-hydroxy-4-(6-methoxy-3-pyridinyl)cyclohexyl]azetidin-3-yl]amino]-2-oxoethyl]-3-methoxybenzamide;N-[2-[[1-[4-hydroxy-4-(6-methoxy-3-pyridinyl)cyclohexyl]azetidin-3-yl]amino]-2-oxoethyl]-3-methylbenzamide;N-[2-[[1-(4-hydroxy-4-pyrimidin-5-ylcyclohexyl)azetidin-3-yl]amino]-2-oxoethyl]-3-(trifluoromethyl)benzamide is sourced from PubChem (CID 160787193), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).